Aquestive Therapeutics, Inc. AQST Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Aquestive Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s interest coverage?
- Aquestive Therapeutics, Inc. (AQST) reported interest coverage of -5× in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s interest coverage changed year-over-year?
- Aquestive Therapeutics, Inc.'s interest coverage decreased by 34.3% year-over-year, from -3.7× to -5×.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s interest coverage?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s interest coverage has grown at a 10.5% compound annual growth rate (CAGR), from -3.9× to -6.4×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.